🔥🐔 BizChicken 🐔🔥

Companies Similar to Oramed Pharmaceuticals Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. logo
Market Cap: Lowest
Employees: Low

Adzenys XR-ODT

Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.

Tags: ADHD, Allergies, Fluoride Deficiency, Healthcare, Insomnia, Pharmaceuticals, Therapeutics

Symbol: AYTU

Recent Price: $1.61

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Joshua R. Disbrow

Sector: Healthcare

Employees: 102

Address: 373 Inverness Parkway, Englewood, CO 80112

Phone: 720 437 6580

Last updated: 2024-12-31

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ORIC-533, ORIC-944, ORIC-114

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.

Tags: ORIC-114, ORIC-533, ORIC-944, biopharmaceutical, cancer treatment, clinical-stage

Symbol: ORIC

Recent Price: $8.17

Industry: Biotechnology

CEO: Dr. Jacob M. Chacko M.B.A., M.D.

Sector: Healthcare

Employees: 107

Address: 240 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 388 5600

Last updated: 2024-12-31

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

Sotagliflozin, LX9211

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.

Tags: biopharmaceutical, drug development, heart failure, neuropathic pain, type 1 diabetes

Symbol: LXRX

Recent Price: $0.72

Industry: Biotechnology

CEO: Dr. Michael Exton Ph.D.

Sector: Healthcare

Employees: 285

Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381

Phone: 281 863 3000

Leadership

  • Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
  • Brian Crum, Senior Vice President and General Counsel
  • Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
  • Mike Exton, Ph.D., Chief Executive Officer and Director
  • Tom Garner, Senior Vice President and Chief Commercial Officer
  • Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
  • Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
  • Wendy McDermott, Senior Vice President, Human Resources
  • Kristen Alexander, Vice President, Finance and Accounting
  • Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
  • Kyle Burt, Vice President, Information Operations
  • Amy Carroll, Ph.D., Vice President, Medical Affairs
  • Melinda Francini, Vice President, Value and Access
  • Desiree Gendron, Vice President, Sales and Training
  • Suma Gopinathan, Ph.D., Vice President, Clinical Development
  • Rachel Martens, Vice President, Partnerships and Corporate Strategy
  • Nicole Moore, Vice President, Legal
  • Tracy Newbold, Vice President, Clinical Operations
  • Godfried Owusu-Ababio, Vice President, Technical Operations
  • Rob Scala, Vice President, Business Planning and Commercial Operations
  • Carrie Siragusa, Vice President, Marketing
  • Dixon Terry, Vice President, Compliance
  • Raymond Debbane, Chairman
  • Philippe J. Amouyal,
  • Samuel L. Barker, PhD,
  • Robert J. Lefkowitz, MD,
  • Christopher J. Sobecki,
  • Diane E. Sullivan,
  • Judith L. Swain, MD,

Last updated: 2024-12-31

Omnicell, Inc.

Omnicell, Inc. logo
Market Cap: High
Employees: High

Omnicell Interface Software, XT Series

Omnicell, Inc. offers medication management solutions and adherence tools for healthcare systems and pharmacies, specializing in point of care automation and dispensing systems.

Tags: automation, healthcare solutions, medication management, pharmacy, robotics

Symbol: OMCL

Recent Price: $43.32

Industry: Medical - Healthcare Information Services

CEO: Mr. Randall A. Lipps

Sector: Healthcare

Employees: 3650

Address: 590 East Middlefield Road, Mountain View, CA 94043

Phone: 650 251 6100

Last updated: 2024-12-31

NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ZYESAMI, NRX-100, NRX-101

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

Tags: CNS disorders, COVID-19 treatment, bipolar depression, clinical-stage pharmaceutical, pulmonary diseases, suicidal behavior

Symbol: NRXP

Recent Price: $1.53

Industry: Biotechnology

CEO: Dr. Jonathan C. Javitt M.D., M.P.H.

Sector: Healthcare

Employees: 2

Address: 1201 Orange Street, Wilmington, DE 19801

Phone: 484 254 6134

Last updated: 2024-12-31

Omeros Corporation

Omeros Corporation logo
Market Cap: Low
Employees: Low

Narsoplimab

Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.

Tags: Narsoplimab, addiction, biopharmaceutical, clinical trials, drug development, immune system, therapeutics

Symbol: OMER

Recent Price: $9.74

Industry: Biotechnology

CEO: Dr. Gregory A. Demopulos M.D.

Sector: Healthcare

Employees: 198

Address: The Omeros Building, Seattle, WA 98119

Phone: 206 676 5000

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

REN001

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.

Tags: Clinical Trials, Genetic Disorders, Mitochondrial Diseases, Pharmaceuticals, Therapeutics

Symbol: RPHM

Recent Price: $18.20

Industry: Biotechnology

CEO: Mr. Gregory J. Flesher

Sector: Healthcare

Employees: 8

Address: 18575 Jamboree Road, Irvine, CA 92612

Phone: 619 733 3852

Last updated: 2024-12-31

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Highest

Emverm, Rytary, Unithroid

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across various dosage forms and therapeutic areas, operating through Generics, Specialty, and Av KARE segments.

Tags: Generics, Healthcare, Pharmaceuticals, Specialty, Therapeutics

Symbol: AMRX

Recent Price: $7.83

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Chirag K. Patel

Sector: Healthcare

Employees: 7850

Address: 400 Crossing Boulevard, Bridgewater, NJ 08807

Phone: 908 947 3120

Leadership

  • Chirag Patel, President and Co-Chief Executive Officer
  • Chintu Patel, Co-Chief Executive Officer
  • Tasos Konidaris, Executive Vice President, Chief Financial Officer
  • Nikita Shah, Executive Vice President, Chief Human Resources Officer
  • Jason B. Daly, Esq., Senior Vice President, Chief Legal Officer & Corporate Secretary
  • Gregory Sgammato, Senior Vice President, Corporate Development
  • Andrew S. Boyer, Executive Vice President, Chief Commercial Officer – Generics
  • Joe Renda, Senior Vice President, Chief Commercial Officer - Specialty
  • Shyamakant Giri, President, India Business & Emerging Markets
  • Sanjay Kumar Jain, PhD, Chief Quality Officer
  • Srinivas Kone, PhD, Senior Vice President, Chief Scientific Officer – Generics
  • Richard D’Souza, PhD, Senior Vice President, Specialty R&D
  • Maryll W. Toufanian, Senior Vice President, Regulatory Strategy and Government Affairs
  • Pranav Mehta, Senior Vice President, Strategic Sourcing & Supply Management
  • Sandeep R. Raktate, President, Operations – India & Ireland

Last updated: 2024-12-31

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

ORLADEYO

Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.

Tags: biotechnology, clinical trials, hereditary angioedema, influenza treatment, oral medicines, small-molecule medicines

Symbol: BCRX

Recent Price: $7.53

Industry: Biotechnology

CEO: Mr. Jon P. Stonehouse

Sector: Healthcare

Employees: 536

Address: 4505 Emperor Boulevard, Durham, NC 27703

Phone: 919 859 1302

Last updated: 2024-12-31

Biora Therapeutics, Inc.

Biora Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

oral biotherapeutics

Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.

Tags: GI diseases, biotechnology, diagnostics, inflammatory bowel diseases, oral biotherapeutics, systemic uptake

Symbol: BIOR

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Aditya P. Mohanty M.B.A.

Sector: Healthcare

Employees: 58

Address: 4330 La Jolla Village Drive, San Diego, CA 92122

Phone: 855 293 2639

Leadership

  • Adi Mohanty, MBA, Chief Executive Officer & Board Member
  • Eric d’Esparbes, Chief Financial Officer
  • Robyn Hatton, Head of Human Resources
  • Ariella Kelman, MD, Chief Medical Officer
  • James Knight, MBA, Head of Business Development
  • Clarke Neumann, JD, General Counsel and Secretary
  • Paul Shabram, MBA, Head of Technical Operations
  • Sharat Singh, PhD, Head of Research
  • Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
  • Jeffrey Alter, MBA, Board Chair
  • Jeffrey Ferrell, Board Member
  • Jill Howe, Board Member
  • Brian Kotzin, MD, Board Member
  • Lynne Powell, MBA, Board Member
  • Bruce Sands, MD, MS, Advisory Board Chair
  • Geert D’Haens, MD, PhD, Advisory Board Member
  • Brian Feagan, MD, FRCPC, Advisory Board Member
  • Séverine Vermeire, MD, PhD, Advisory Board Member
  • Satish Rao, MD, PhD, Advisory Board Chair
  • William Chey, MD, Advisory Board Member
  • Anthony Lembo, MD, Advisory Board Member
  • Mark Pimentel, MD, Advisory Board Member

Last updated: 2024-12-31

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex

Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.

Tags: gastroenterology, hospital care, oncology, pharmaceutical, prescription products, rheumatology

Symbol: CPIX

Recent Price: $2.42

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. A. J. Kazimi MBA

Sector: Healthcare

Employees: 91

Address: 2525 West End Avenue, Nashville, TN 37203

Phone: 615 255 0068

Last updated: 2024-12-31

MediciNova, Inc.

MediciNova, Inc. logo
Market Cap: Low
Employees: Lowest

MN-166 (ibudilast)

Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.

Tags: United States, biopharmaceutical, fibrotic diseases, neurological disorders, novel therapeutics, solid tumors, unmet medical needs

Symbol: MNOV

Recent Price: $2.11

Industry: Biotechnology

CEO: Dr. Yuichi Iwaki M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 4275 Executive Square, La Jolla, CA 92037

Phone: 858 373 1500

Leadership

  • Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
  • Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
  • David H. Crean, Ph.D., Chief Business Officer
  • Jason J. Kruger, CPA (inactive), Chief Financial Officer
  • Hideki Nagao, Member of the Board of Directors
  • Carolyn Beaver, Member of the Board of Directors
  • Nicole Lemerond, CFA, Member of the Board of Directors

Last updated: 2024-12-31

Modular Medical, Inc.

Modular Medical, Inc. logo
Market Cap: Lowest
Employees: Lowest

MODD1

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps to enhance pump adoption in the diabetes marketplace.

Tags: diabetes care, healthcare, insulin pump, medical device, technology

Symbol: MODD

Recent Price: $1.39

Industry: Medical - Devices

CEO: Mr. James E. Besser

Sector: Healthcare

Employees: 39

Address: 16772 W. Bernardo Drive, San Diego, CA 92127

Phone: 858 800 3500

Last updated: 2024-12-31

Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. logo
Market Cap: Low
Employees: Lowest

ORMD-0801

Oramed Pharmaceuticals Inc. focuses on the research and development of oral pharmaceutical solutions, specifically for diabetes treatment using orally ingestible capsules for polypeptide delivery. Their flagship product, ORMD-0801, is an oral insulin capsule.

Tags: Diabetes, ORMD-0801, Oral Insulin, Pharmaceuticals, Research and Development

Symbol: ORMP

Recent Price: $2.33

Industry: Biotechnology

CEO: Mr. Nadav Kidron Esq.

Sector: Healthcare

Employees: 13

Address: 1185 Avenue of the Americas, New York, NY 10036

Phone: 844 967 2633

Last updated: 2024-12-31

Ovid Therapeutics Inc.

Ovid Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

OV101, OV329, OV350, OV882, OV815

Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.

Tags: biopharmaceutical, clinical trials, medicine development, neurological disorders

Symbol: OVID

Recent Price: $0.96

Industry: Biotechnology

CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Sector: Healthcare

Employees: 40

Address: 1460 Broadway, New York, NY 10036

Phone: 646 661 7661

Leadership

  • Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
  • Meg Alexander, President and Chief Operating Officer
  • Zhong Zhong, Ph.D., Chief Scientific Officer
  • Jeffrey Rona, Chief Business and Financial Officer
  • Amanda Banks, M.D., Chief Development Officer
  • Julia Tsai, Ph.D., Senior Vice President of Clinical Development
  • Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
  • Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
  • Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
  • Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
  • Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee

Last updated: 2024-12-31

Revolution Medicines, Inc.

Revolution Medicines, Inc. logo
Market Cap: Highest
Employees: Medium

RMC-4630

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing therapies targeting frontier targets in RAS-addicted cancers.

Tags: RAS-addicted cancers, cancer therapy, clinical trials, oncology, precision medicine

Symbol: RVMD

Recent Price: $43.17

Industry: Biotechnology

CEO: Dr. Mark A. Goldsmith Ph.D.

Sector: Healthcare

Employees: 378

Address: 700 Saginaw Drive, Redwood City, CA 94063

Phone: 650 481 6801

Last updated: 2024-12-31

Insulet Corporation

Insulet Corporation logo
Market Cap: Highest
Employees: High

Omnipod System

Insulet Corporation develops, manufactures, and sells insulin delivery systems, offering the Omnipod System, a tubeless device for insulin-dependent diabetes management.

Tags: diabetes management, healthcare, innovation, insulin delivery, medical devices

Symbol: PODD

Recent Price: $263.36

Industry: Medical - Devices

CEO: Dr. James R. Hollingshead Ph.D.

Sector: Healthcare

Employees: 3000

Address: 100 Nagog Park, Acton, MA 01720

Phone: 978 600 7000

Last updated: 2024-12-31

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

resmetirom

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.

Tags: biopharmaceutical, cardiovascular, clinical-stage, liver diseases, metabolic, non-alcoholic steatohepatitis, resmetirom, therapeutic candidates

Symbol: MDGL

Recent Price: $311.62

Industry: Biotechnology

CEO: Mr. William J. Sibold

Sector: Healthcare

Employees: 376

Address: Four Tower Bridge, West Conshohocken, PA 19428

Phone: 267 824 2827

Leadership

  • BILL SIBOLD, Chief Executive Officer
  • REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
  • MARDI C. DIER, Chief Financial Officer
  • CAROLE HUNTSMAN, Chief Commercial Officer
  • CLINT WALLACE, Chief Human Resources Officer
  • RONALD FILIPPO, Chief Information Officer
  • STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
  • SHANNON KELLEY, General Counsel
  • MARK BARRETT, Chief Business Officer
  • MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
  • Julian C. Baker, Chairman and Director
  • Kenneth M. Bate, Director
  • Raymond Cheong, M.D., Ph.D., Director
  • Fred Craves, Ph.D., Director
  • James M. Daly, Director
  • Paul A. Friedman, M.D., Director
  • Richard S. Levy, M.D., Director
  • Bill Sibold, Director, Chief Executive Officer
  • Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31